Fulgent Genetics (FLGT) Cash from Investing Activities Growth (1y) (2016 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Cash from Investing Activities Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -165.43% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -8.06% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -289.16% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 1,052.89% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -16.62% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -8,716.16% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -38.65% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | -40.88% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -1,399.37% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -4.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.87% |
| Mar 31, 2026 | -60.55% |
| Dec 31, 2025 | 140.63% |
| Sep 30, 2025 | 112.40% |
| Jun 30, 2025 | 631.16% |
| Mar 31, 2025 | 158.77% |
| Dec 31, 2024 | -213.12% |
| Sep 30, 2024 | -55.25% |
| Jun 30, 2024 | 766.42% |
| Mar 31, 2024 | -983.74% |
| Dec 31, 2023 | 126.21% |
| Sep 30, 2023 | -54.67% |
| Jun 30, 2023 | 99.49% |
| Mar 31, 2023 | -732.85% |
| Dec 31, 2022 | 33.98% |
| Sep 30, 2022 | 227.29% |
| Jun 30, 2022 | -37.86% |
| Mar 31, 2022 | 100.32% |
| Dec 31, 2021 | 56.00% |
| Sep 30, 2021 | -2,378.13% |